Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
La nit de la Recerca
Scientists from all over Catalonia share their work through talks, workshops, demonstrations, and games for all ages at the Nit…
ERC Public Engagement with Research Awards 2026
Prof. Karim Lekadir has been recognised with one of the ERC Public Engagement with Research Awards 2026 for his work…